Seroquel user wants FDA to see sealed papers

A patient who claims the psychiatric drug Seroquel gave him diabetes has asked a judge to unseal AstraZeneca's confidential documents about its side effects--before the FDA decides whether to grant a new indication covering millions of patients with depression and/or anxiety. Report

Suggested Articles

Pfizer isn't giving up in biosims. This week, it unveiled launches to three Roche blockbusters, with two already on the market.

Novo Nordisk is betting big on GLP-1 Saxenda in its global obesity push, but England's cost watchdog is unimpressed with the drug's long-term outlook.

Tecentriq didn’t show benefit against simple observation at delaying cancer recurrence or death in patients with muscle-invasive urothelial cancer.